Cannon Advisors’s Eli Lilly LLY Stock Holding History

Cannon Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-950	Closed	-$1.09M	–	115
2026 Q2	$1.09M	Buy	+950	New	+$971K	0.67%	40

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Cannon Advisors's LLY Position: Q3 2026 in Review

Cannon Advisors sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 950 shares — an estimated $1.09M sold.

Cannon Advisors first reported a position in LLY in Q2 2026 and held it in 1 quarter. The position peaked at $1.09M in Q2 2026. 1,273 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Cannon Advisors reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
Cannon Advisors sold 950 Eli Lilly shares in Q3 2026, an estimated $1.09M.
Cannon Advisors first reported a position in Eli Lilly in Q2 2026 and held it in 1 quarter.
Cannon Advisors's Eli Lilly position peaked at $1.09M in Q2 2026.
1,273 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cannon Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.